Navigation Links
American Chemical Society's Weekly PressPac -- Jan. 28, 2009
Date:2/2/2009

ropical Products Laboratory
Agricultural Research Service
U.S. Department of Agriculture
Winter Haven, Fla. 33881
Phone: (863) 293-4133
Fax: (863) 299 8678
E-mail: kyung.myung@ars.usda.gov


ARTICLE #2 FOR IMMEDIATE RELEASE

Toward a urine test for diagnosing heart disease
Journal of Proteome Research

Researchers in Australia are reporting an advance toward the first urine test for diagnosing coronary artery disease (CAD), the condition responsible for most of the 1.5 million heart attacks that occur in the United States each year. The test could save lives in the future by allowing earlier diagnosis and monitoring of the disease, which is the No. 1 cause of death in the United States, the researchers say. Their report is in the Nov. 19, 2008 issue of ACS' Journal of Proteome Research, a monthly publication.

In the new study, Karlheinze Peter and colleagues note that the most reliable test for diagnosing CAD is angiography, an invasive test in which doctors inject special dyes into the body to visualize, via X-rays, fatty plaque deposits in the arteries of the heart. However, the technique is invasive, expensive, time-consuming, and may miss CAD in its earliest stages, they say.

To develop a faster, more convenient test, the scientists collected urine samples from a group of 67 patients 41 with CAD and 26 without and analyzed the samples for differences in protein content. Using a newly developed method, they identified a group of 17 peptides (building blocks of proteins) that appear to be directly associated with CAD. These urine-based peptides indicated the presence of the disease with an 84 percent accuracy rate when compared to CAD cases confirmed using angiography, the researchers say, underscoring their potential for diagnostic screening. MTS

ARTICLE #2 FOR IMMEDIATE RELEASE
"Evaluation
'/>"/>

Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
Source:Eurekalert  

Page: 1 2 3 4 5 6

Related biology news :

1. Carnegies Joe Berry elected Fellow of the American Geophysical Union
2. American Association for Cancer Research hosts Science of Cancer Health Disparities conference
3. American Chemical Societys weekly PressPac -- Jan. 14, 2009
4. American Chemical Societys Weekly PressPac -- Jan. 7, 2009
5. American Association for Cancer Research hosts Science of Health Care Disparities Meeting
6. News from the January 2009 Journal of the American Dietetic Association
7. Tips from the American Journal of Pathology
8. UT faculty members win American Heart Association awards for advancing research
9. American Chemical Societys Weekly PressPac -- Dec. 17, 2008
10. 13 UCR faculty members recognized by American Association for the Advancement of Science
11. American Association for the Advancement of Science honors four Iowa Staters
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
American Chemical Society's Weekly PressPac -- Jan. 28, 2009
(Date:2/13/2015)... TAIPEI , Feb. 13, 2015 ... service company that aims to transform cancer genomic ... announced that the company has raised US$ 8 million ... Based in Taipei, Taiwan ... tests, ACTDrug™, ACTOnco™. With the aim to implement ...
(Date:2/9/2015)... , Feb. 9, 2015  Lintec of America ... methods for carbon nanotube (CNT) macrostructures, including sheets, yarns ... Dallas (UTD). Leveraging the vast industrial resources ... Tokyo, Japan , Lintec of America is forming ... Richardson, TX , focusing on scaling up the ...
(Date:2/5/2015)... 2015   Marvin Test Solutions , ... test solutions for military, aerospace, and manufacturing ... TS-323 GENASYS Test Platform to ... is a high-performance PXI-based system designed to ... require performance functional testing. GENASYS features a ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4
... PITTSBURGH, Oct. 23 A new study suggests that viruses ... cells while promoting the growth of surviving cells with cancerous ... wiping out normal cells that support the replication of viruses ... their circuitry. When this process is repeated over and over, ...
... David Jones, a fisheries oceanographer at the Cooperative Institute for ... Miamis Rosenstiel School, set out to design a better light ... invention would contribute to the discovery of a new species. ... known description, his catch turned out to be the answer ...
... Captains Log originally used with individuals diagnosed ... learning disabilities is being adapted to rehabilitate ... Michael Boivin, a Michigan State University associate ... and Bruno Giordani, a University of Michigan associate ...
Cached Biology News:Study proposes new theory of how viruses may contribute to cancer 2New light trap captures larval stage of new species; DNA barcode technology used 2MSU researcher helps develop computer game for Ugandan children recovering from cerebral malaria 2
(Date:2/27/2015)... Feb. 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... studies for its newly developed Bruton,s tyrosine kinase ... been completed. The results of these preclinical evaluations ... Drug Administration. The feedback received from the Agency ... first-in-human study. Additional preclinical work is required to ...
(Date:2/27/2015)... Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) has ... Trypsin" report to their offering. , ... comprehensive data on Trypsin globally and regionally ( Europe ... America , Latin America etc.). ... This report focuses on three primary areas; manufacture ...
(Date:2/27/2015)... 27, 2015 The fully automated ... UC) can sequentially analyze up to 48 samples ... high-sensitivity detection of targets by mass spectrometry. ... fulfill the measurement requirements of a wide range ... drug delivery and search for disease biomarkers, additives ...
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE ... development of biosimilar therapeutics, today announced that it will ... Marriott Marquis on March 2 nd at 3pm ... on a panel discussing the current state of the ... Biosimilars . For more information on ...
Breaking Biology Technology:Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 2Pharmacyclics Provides Clinical Update on BTK Inhibitor for Autoimmune Diseases 3Global Market Report of Trypsin 2014-2018 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3
... Pharmaceuticals, Inc. (NASDAQ: ANPI , TSX: ... Scientific Corporation (NYSE: BSX ) has ... with left main coronary disease who were treated ... SYNTAX-LE MANS is a substudy of the landmark ...
... ( http://www.gene2drug.com ) -- the ... science industry -- announces the publication of its latest ... for Commercial Suppliers, Vol. III." Given the highly ... report is designed to create opportunities for differentiation by ...
... Cholesterol Test for determining heart disease riskBIRMINGHAM, Ala., May ... developer of the VAP Cholesterol Test, has announced it ... and report apolipoprotein B100 (apoB) using the Vertical Auto ... of the VAP Cholesterol Test to accurately report apoB, ...
Cached Biology Technology:SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 2SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 3SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 4SYNTAX substudy shows positive outcomes for left main patients treated with TAXUS(R) Express(2)(R) Stent System 5BioInformatics, LLC New Report -- The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III 2Atherotech Receives Patent for ApoB Measurement 2Atherotech Receives Patent for ApoB Measurement 3
...
Borrelia Burgdorfen (IgG) -Ab EIA Sample Size: 100 l...
... is a protein ribonuclease inhibitor that noncovalently binds ... inhibition is seen with RNase 1, T1, T2, ... from human placental ribonuclease inhibitor in that it ... does not release active RNase in the absence ...
... Inkjet Printer) is a revolutionary new ... Protein Macroarray Analysis, developed in conjunction ... strategy compliments established protocols in resolving ... proteins isoelectric point and apparent molecular ...
Biology Products: